Kupffer cells support extramedullary erythropoiesis induced by nitrogen-containing bisphosphonate in splenectomized mice

Cellular Immunology

Volumn 271, Issue 1, 2011, Pages 197-204

  Otsuka, Hirotada ^a   Yagi, Hideki ^b   Endo, Yasuo ^c   Nonaka, Naoko ^a   Nakamura, Masanori ^a  

^a SHOWA UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Extramedullary erythropoiesis; Kupffer cell; Nitrogen containing bisphosphonate (NBP)

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ERYTHROPOIETIN; NITROGEN; STROMAL CELL DERIVED FACTOR 1; VASCULAR CELL ADHESION MOLECULE 1;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; COLONY FORMING UNIT; CONTROLLED STUDY; ERYTHROBLAST; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; KUPFFER CELL; LIVER; LIVER SINUSOID; MEGAKARYOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLENECTOMY;

ANIMALS; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION; BLOOD GROUP ANTIGENS; BONE MARROW; DIPHOSPHONATES; ERYTHROBLASTS; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; GENE EXPRESSION; HEMATOCRIT; IMMUNOHISTOCHEMISTRY; KUPFFER CELLS; LIVER; MACROPHAGES; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; RECEPTORS, ERYTHROPOIETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLENECTOMY; VASCULAR CELL ADHESION MOLECULE-1;

MUS;

EID: 80052359352     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.06.025     Document Type: Article

References (49)

1. Lenox L.E., Perry J.M., Paulson R.F. BMP4 and Madh5 regulate the erythroid response to acute anemia. Blood 2005, 105:2741-2748.
2. Bowling M.R., Cauthen C.G., Perry C.D., Patel N.P., Bergman S., Link K.M., Sane A.C., Conforti J.F. Pulmonary extramedullary hematopoiesis. J. Thorac. Imaging 2008, 23:138-141.
3. Meo A., Cassinerio E., Castelli R., Bignamini D., Perego L., Cappellini M.D. Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia: case reports and literature review. Int. J. Lab. Hematol. 2008, 30:425-431.
4. Halder R.C., Abe T., Mannoor M.K., Morshed S.R., Ariyasinghe A., Watanabe H., Kawamura H., Sekikawa H., Hamada H., Nishiyama Y., Ishikawa H., Toba K., Abo T. Onset of hepatic erythropoiesis after malarial infection in mice. Parasitol. Int. 2003, 52:259-268.
5. McGrath K., Palis J. Ontogeny of erythropoiesis in the mammalian embryo. Curr. Top Dev. Biol. 2008, 82:1-22.
6. Tsiftsoglou A.S., Vizirianakis I.S., Strouboulis J. Erythropoiesis: model systems molecular regulators, and developmental programs. IUBMB Life 2009, 61:800-830.
7. Palis J. Molecular Biology of Erythropoiesis. Molecular Basis of Hematopoiesis, Springer Science+Bussiness Media 2009, 73-93. LLC, New York. A. Wickerema, B. Kee (Eds.).
8. Bessis M., Mize C., Prenant M. Erythropoiesis: comparison of in vivo and in vitro amplification. Blood Cells 1978, 4:155-174.
9. Seshi B., Kumar S., Sellers D. Human bone marrow stromal cell: coexpression of markers specific for multiple mesenchymal cell lineages. Blood Cells Mol. Dis. 2000, 26:234-246.
10. Notsu E., Sonoda Y., Sasaki K. A histological study and three-dimensional reconstruction of F4/80-positive reticular cells and macrophages at the onset of murine bone marrow hematopoiesis. Kaibogaku Zasshi 2007, 82:53-60.
11. Mohandas N., Prenant M. Three-dimensional model of bone marrow. Blood 1978, 51:633-643.
12. Sasaki K., Iwatsuki H. Origin and fate of the central macrophages of erythroblastic islands in the fetal and neonatal mouse liver. Microsc. Res. Tech. 1997, 39:398-405.
13. Li D., Wang G.Y., Liu Z.F., Shi Y.X., Zhang H., Bai Z.L. Macrophage-associated erythropoiesis and lymphocytopoiesis in mouse fetal liver: ultrastructural and ISH analysis. Cell Biol. Int. 2004, 28:457-461.
14. Manwani D., Bieker J.J. The erythroblastic island. Curr. Top. Dev. Biol. 2008, 82:23-53.
15. Chasis J.A., Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood 2008, 112:470-478.
16. Soni S., Bala S., Gwynn B., Sahr K.E., Peters L.L., Hanspal M. Absence of erythroblast macrophage protein (Emp) leads to failure of erythroblast nuclear extrusion. J. Biol. Chem. 2006, 281:20181-20189.
17. Soni S., Bala S., Kumar A., Hanspal M. Changing pattern of the subcellular distribution of erythroblast macrophage protein (Emp) during macrophage differentiation. Blood Cells Mol. Dis. 2007, 38:25-31.
18. Sadahira Y., Mori M. Role of the macrophage in erythropoiesis. Pathol. Int. 1999, 49:841-848.
19. Hanspal M., Hanspal J.S. The association of erythroblasts with macrophages promotes erythroid proliferation and maturation: a 30-kD heparin-binding protein is involved in this contact. Blood 1994, 84:3494-3504.
20. Body J.J. Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions. Breast 2003, 12(Suppl. 2):S37-44.
21. Cremers S.C., Eekhoff M.E., Den Hartigh J., Hamdy N.A., Vermeij P., Papapoulos S.E. Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of bone. J. Bone Miner. Res. 2003, 18:868-875.
22. Escudero N.D., Lacave M., Ubios A.M., Mandalunis P.M. Effect of monosodium olpadronate on osteoclasts and megakaryocytes: an in vivo study. J. Musculoskelet. Neuronal. Interact. 2009, 9:109-120.
23. Endo Y., Shibazaki M., Yamaguchi K., Nakamura M., Kosugi H. Inhibition of inflammatory actions of aminobisphosphonates by dichloromethylene bisphosphonate. A non-aminobisphosphonate. Br. J. Pharmacol. 1999, 126:903-910.
24. Kellinsalmi M., Monkkonen H., Monkkonen J., Leskela H.V., Parikka V., Hamalainen M., Lehenkari P. In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts. Basic Clin. Pharmacol. Toxicol. 2005, 97:382-391.
25. Bringmann A., Schmidt S.M., Weck M.M., Brauer K.M., von Schwarzenberg K., Werth D., Grunebach F., Brossart P. Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells. Leukemia 2007, 21:732-738.
26. Yamaguchi K., Oizumi T., Funayama H., Kawamura H., Sugawara S., Endo Y. Osteonecrosis of the jawbones in two osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale. J. Oral Maxillofac. Surg. 2010, 68:889-897.
27. Nakamura M., Yagi H., Endo Y., Kosugi H., Ishi T., Itoh T. A time kinetic study of the effect of aminobisphosphonate on murine haemopoiesis. Br. J. Haematol. 1999, 107:779-790.
28. Claassen I., Van Rooijen N., Claassen E. A new method for removal of mononuclear phagocytes from heterogeneous cell populations in vitro, using the liposome-mediated macrophage 'suicide' technique. J. Immunol. Methods 1990, 134:153-161.
29. Nagel M.D., Nagel J. Erythroid colony formation by fetal rat liver and spleen cells in vitro: inhibition by a low relative molecular mass component of fetal spleen. Development 1992, 114:213-219.
30. Aispuru G.R., Aguirre M.V., Aquino-Esperanza J.A., Lettieri C.N., Juaristi J.A., Brandan N.C. Erythroid expansion and survival in response to acute anemia stress: the role of EPO receptor, GATA-1, Bcl-xL and caspase-3. Cell Biol. Int. 2008, 32:966-978.
31. Rogers M.J., Chilton K.M., Coxon F.P., Lawry J., Smith M.O., Suri S., Russell R.G. Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism. J. Bone Miner. Res. 1996, 11:1482-1491.
32. Sansoni P., Passeri G., Fagnoni F., Mohagheghpour N., Snelli G., Brianti V., Engleman E.G. Inhibition of antigen-presenting cell function by alendronate in vitro. J. Bone Miner. Res. 1995, 10:1719-1725.
33. Soni S., Bala S., Hanspal M. Requirement for erythroblast-macrophage protein (Emp) in definitive erythropoiesis. Blood Cells Mol. Dis. 2008, 41:141-147.
34. Debili N., Coulombel L., Croisille L., Katz A., Guichard J., Breton-Gorius J., Vainchenker W. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood 1996, 88:1284-1296.
35. Suda T., Suda J., Ogawa M. Single-cell origin of mouse hemopoietic colonies expressing multiple lineages in variable combinations. Proc. Natl. Acad. Sci. USA 1983, 80:6689-6693.
36. Cho K., Seki S., Nakatani K., Kobayashi K., Kaneda K. Kupffer cell activation and hematopoiesis in the liver of autoimmune MRL-lpr/lpr mice. Arch. Histol. Cytol. 2000, 63:473-483.
37. Walker L., Lynch M., Silverman S., Fraser J., Boulter J., Weinmaster G., Gasson J.C. The Notch/Jagged pathway inhibits proliferation of human hematopoietic progenitors in vitro. Stem Cells 1999, 17:162-171.
38. Pui J.C., Allman D., Xu L., DeRocco S., Karnell F.G., Bakkour S., Lee J.Y., Kadesch T., Hardy R.R., Aster J.C., Pear W.S. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 1999, 11:299-308.
39. Rothenberg E.V. Stepwise specification of lymphocyte developmental lineages. Curr. Opin. Genet. Dev. 2000, 10:370-379.
40. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
41. Sugiyama Y., Koike T., Shiojiri N. Developmental changes of cell adhesion molecule expression in the fetal mouse liver. Anat. Rec. 2010, 293:1698-1710.
42. Yamashita T., Ohneda O., Sakiyama A., Iwata F., Ohneda K., Fuji-Kuriyama Y. The microenvironment for erythropoiesis is regulated by HIF-2α through VCAM-1 in endothelial cells. Blood 2008, 112:1482-1492.
43. Eckardt K.U., Pugh C.W., Meier M., Tan C.C., Ratcliffe P.J., Kurtz A. Production of erythropoietin by liver cells in vivo and in vitro. Ann. N. Y. Acad. Sci. 1994, 718:50-60.
44. Paul P., Rothmann S.A., McMahon J.T., Gordon A.S. Erythropoietin secretion by isolated rat Kupffer cells. Exp. Hematol. 1984, 12:825-830.
45. Huang X., Pierce L.J., Chen G.L., Chang K.T., Spangrude G.J., Prchal J.T. Erythropoietin receptor signaling regulates both erythropoiesis and megakaryopoiesis in vivo. Blood Cells Mol. Dis. 2010, 44:1-6.
46. Lisowska K.A., Debska-Slizien A., Bryl E., Rutkowski B., Witkowski J.M. Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment. Artif. Organs 2010, 34:654-662.
47. Fairchild Benyo D., Conrad K.P. Expression of the erythropoietin receptor by trophoblast cells in the human placenta. Biol. Reprod. 1999, 60:861-870.
48. Santhanam A.V., D'Uscio L.V., Katusic Z.S. Cardiovascular effects of erythropoietin an update. Adv. Pharmacol. 2010, 60:257-285.
49. Sugawa M., Sakurai Y., Ishikawa-Ieda Y., Suzuki H., Asou H. Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci. Res. 2002, 44:391-403.